Literature DB >> 32905978

Experience of trans-nasal endoscopic surgery for pituitary tumors in a single center in China: Surgical results in a cohort of 2032 patients, operated between 2006 and 2018.

Chuzhong Li1, Haibo Zhu2, Xuyi Zong2, Xinsheng Wang2, Songbai Gui2, Peng Zhao2, Jiwei Bai2, Chunhui Liu2, Lei Cao2, Zhenye Li2, Yazhuo Zhang3.   

Abstract

OBJECTIVES: This study was conducted to investigate complications and outcome by endonasal endoscopic approach in our single center. PATIENTS AND METHODS: The clinical data of 2032 pituitary adenoma surgeries performed in our ward between January 2006 and December 2018 were retrospectively reviewed. The GTR (gross total resection) rate, hormonal control, complications, and tumor recurrence rate were retrospectively analyzed.
RESULTS: There were 628 (83.5 %) preoperative headache patients, 513 (68.9 %) visual acuity and visual field impaired patients, 218 (66.4 %) endocrine symptom patients and 26 (53.1 %) SIADH (syndrome of inappropriate secretion of antidiuretic hormone) patients experienced improvement after surgery. GTR was achieved in 1627 patients (80.1 %) and NGTR (non-gross total resection) in 405 patients (19.9 %). Clinically variable analyses revealed a significant correlation between GTR and Knosp's grades, large tumor volume, bone-invasive and recurrent tumors. Postoperative complications mainly included 34 (1.7 %) CSF (cerebral spinal fluid) leak, 72 (3.5 %) pituitary insufficiency, 30 (1.5 %) meningitis, 20 (0.98 %) cranial nerve deficits, 5 (0.25 %) hematoma, 5 (0.25 %) patients with internal carotid artery injury, and other complications mainly included nasal complications occurred in 168 patients (8.6 %). Overall, there were 3 deaths (0.15 %) occurred in our series. Univariate analysis showed that larger tumors, invasion, bone invasive, recurrent tumors and NGTR were associated with tumor regrowth. Multivariate analysis showed that NGTR and invasion were independent risk factors for tumor regrowth.
CONCLUSIONS: NGTR and invasion were independent risk factors for tumor regrowth. Endoscopic surgery is an excellent choice for pituitary adenomas. It has the advantages of being minimally invasive, safe, and efficacious.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Complications; Endonasal endoscopics; Outcome; Pituitary adenomas

Mesh:

Year:  2020        PMID: 32905978     DOI: 10.1016/j.clineuro.2020.106176

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

Review 1.  Carotid artery injury in endoscopic endonasal surgery: Risk factors, prevention, and management.

Authors:  Rahul K Sharma; Alexandria L Irace; Jonathan B Overdevest; David A Gudis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-03-22

Review 2.  Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions.

Authors:  Liang Lu; Xueyan Wan; Yu Xu; Juan Chen; Kai Shu; Ting Lei
Journal:  Diagnostics (Basel)       Date:  2022-04-13

3.  Expression and clinical significance of Cathepsin K and MMPs in invasive non-functioning pituitary adenomas.

Authors:  Hongyan Liu; Saichun Zhang; Ting Wu; Zhaohui Lv; Jianming Ba; Weijun Gu; Yiming Mu
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

4.  Analysis of neuroendoscopy for the treatment of macroadenomas and giant pituitary adenomas.

Authors:  Junyong Wu; Binbin Zhang; Dongqi Shao; Shuxin Ji; Yu Li; Shan Xie; Zhiquan Jiang
Journal:  Front Surg       Date:  2022-08-11

5.  A Preoperative MRI-Based Radiomics-Clinicopathological Classifier to Predict the Recurrence of Pituitary Macroadenoma Within 5 Years.

Authors:  Yu Zhang; Yuqi Luo; Xin Kong; Tao Wan; Yunling Long; Jun Ma
Journal:  Front Neurol       Date:  2022-01-05       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.